M. Kathleen Clark
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
M. Kathleen Clark has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Sara Nichols
Reprint requests to: M. Kathleen Clark, PhD, College of Nursing, 434 NB, University of Iowa, Iowa City, IA 52242.
4 shared publications- Barcey T. Levy
University of Iowa Carver College of Medicine, University of Iowa College of Public Health; and Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa, USA
3 shared publications - Joseph S. Dillon
Holden Comprehensive Cancer Center, University of Iowa , Iowa City, IA
2 shared publications MaryFran R. Sowers
Department of Epidemiology, School of Public Health, The University of Michigan, Ann Arbor, Michigan
2 shared publicationsMaryFran Sowers
College of Public Health, University of Michigan, Ann Arbor, Michigan
2 shared publications- Amy Hahn
The University of Iowa College of Public Health, Department of Biostatistics, 145 N Riverside Drive, Iowa City, IA 52242, United States
1 shared publication
Latest Publications
- 1 September 2020
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 14 (5) , 421-427
Enacted weight stigma and weight self stigma prevalence among 3821 adults
- 1 September 2020
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 14 (5) , 421-427
Enacted weight stigma and weight self stigma prevalence among 3821 adults
- 1 July 2011
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 15 (3) , 219-223
Differences in Cervical Cytologic and Histologic Findings Between Women Using Depot-Medroxyprogesterone Acetate and Oral Contraceptives
Objective. This study aimed to compare cervical cytologic and histologic findings between women using depot-medroxyprogesterone acetate (DMPA) and oral contraceptives (OCs) referred for colposcopy and to determine whether there were differences in the occurrence of false-positive cytologic finding between the 2 contraceptive groups. Materials and Methods. Retrospective cohort of 1,569 premenopausal women using either DMPA or OC who were evaluated for abnormal cervical cytologic findings. Cytologic and histologic data were collected in conjunction with routine gynecologic examinations or follow-up colposcopic evaluations. χ2 tests were used to determine differences in cervical cytologic and histologic findings and the proportion of false-positive results across contraceptive groups. Nominal logistic regression was used to evaluate the association between contraceptive use, cervical, and histologic abnormalities while controlling or age and smoking status. Results. The mean age of all participants was 23.5 years, with no significant difference between OC (n = 1194) and DMPA (n = 375) users. Although there were no differences in the proportion of false-positive cytologic results (21.8% overall), DMPA users were more likely to smoke (p < .001), have atypical glandular cell (AGC) on referral cytology (p < .001), and have histologic confirmation of cervical intraepithelial neoplasia 2, 3 (p = .004). Users of DMPA remained more likely to have AGC cytology after considering smoking status; however, cervical intraepithelial neoplasia 2, 3 was found to be associated with smoking status and not use of DMPA. Conclusions. We found no difference in the proportion of false-positive cytologic results between DMPA and OC users referred for evaluation of abnormal cytology. Users of DMPA were more likely to have AGC, which necessitates a more comprehensive evaluation.
- 1 July 2011
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 15 (3) , 219-223
Differences in Cervical Cytologic and Histologic Findings Between Women Using Depot-Medroxyprogesterone Acetate and Oral Contraceptives
Objective. This study aimed to compare cervical cytologic and histologic findings between women using depot-medroxyprogesterone acetate (DMPA) and oral contraceptives (OCs) referred for colposcopy and to determine whether there were differences in the occurrence of false-positive cytologic finding between the 2 contraceptive groups. Materials and Methods. Retrospective cohort of 1,569 premenopausal women using either DMPA or OC who were evaluated for abnormal cervical cytologic findings. Cytologic and histologic data were collected in conjunction with routine gynecologic examinations or follow-up colposcopic evaluations. χ2 tests were used to determine differences in cervical cytologic and histologic findings and the proportion of false-positive results across contraceptive groups. Nominal logistic regression was used to evaluate the association between contraceptive use, cervical, and histologic abnormalities while controlling or age and smoking status. Results. The mean age of all participants was 23.5 years, with no significant difference between OC (n = 1194) and DMPA (n = 375) users. Although there were no differences in the proportion of false-positive cytologic results (21.8% overall), DMPA users were more likely to smoke (p < .001), have atypical glandular cell (AGC) on referral cytology (p < .001), and have histologic confirmation of cervical intraepithelial neoplasia 2, 3 (p = .004). Users of DMPA remained more likely to have AGC cytology after considering smoking status; however, cervical intraepithelial neoplasia 2, 3 was found to be associated with smoking status and not use of DMPA. Conclusions. We found no difference in the proportion of false-positive cytologic results between DMPA and OC users referred for evaluation of abnormal cytology. Users of DMPA were more likely to have AGC, which necessitates a more comprehensive evaluation.
- 1 April 2011
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 5 (2) , e85-e92
BMI misclassification, leptin, C-reactive protein, and interleukin-6 in young women with differing levels of lean and fat mass
- 1 April 2011
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 5 (2) , e85-e92
BMI misclassification, leptin, C-reactive protein, and interleukin-6 in young women with differing levels of lean and fat mass
- 1 November 2006
- Published by Elsevier in Fertility and Sterility
- Vol. 86 (5) , 1466-1474
Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate
- 1 November 2006
- Published by Elsevier in Fertility and Sterility
- Vol. 86 (5) , 1466-1474
Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate
- 28 June 2005
- Published by Springer Nature in International Journal of Obesity
- Vol. 29 (10) , 1252-1258
Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception
OBJECTIVE: DESIGN: SUBJECTS: MEASUREMENTS: RESULTS: CONCLUSIONS:
- 28 June 2005
- Published by Springer Nature in International Journal of Obesity
- Vol. 29 (10) , 1252-1258
Weight, fat mass, and central distribution of fat increase when women use depot-medroxyprogesterone acetate for contraception
OBJECTIVE: DESIGN: SUBJECTS: MEASUREMENTS: RESULTS: CONCLUSIONS:
- 1 December 2004
- Published by Elsevier in Fertility and Sterility
- Vol. 82 (6) , 1580-1586
Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate
- 1 December 2004
- Published by Elsevier in Fertility and Sterility
- Vol. 82 (6) , 1580-1586
Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate
- 1 June 2003
- Published by Springer Nature in Osteoporosis International
- Vol. 14 (5) , 396-403
Bone mineral density and fractures among alcohol-dependent women in treatment and in recovery
Women are at higher risk for osteoporosis, but most of the literature examining the effect of alcohol abuse on bone mineral density (BMD) has been in men. The aim of this study was to determine differences in BMD and fracture prevalence among women in treatment for alcohol abuse, in recovery and non-alcohol-dependent women. This cross-sectional study was completed at two residential substance abuse centers in Iowa (USA). The patients were Caucasian women, aged 18–70 years, in treatment for alcohol abuse and dependence (n=228); in recovery and abstaining from alcohol (n=156); and women with no history of alcohol abuse (n=447). The main outcome measures were femoral neck and lumbar spine BMD measured by dual-energy X-ray absorptiometry (DXA); self-reported lifetime fracture prevalence. After adjusting for age and menopausal status, women in treatment had BMDs that were 7.7% (ppppp<0.01). Women in recovery also reported significantly greater numbers of fractures following sobriety than their paired non-alcohol-dependent counterparts. Alcohol abuse and dependence was associated with lower femoral neck and lumbar spine BMD. Women with histories of alcohol dependence had a higher lifetime prevalence of fractures, including time periods before the onset of problem drinking and following abstinence, suggesting that factors other than acute intoxication contributed to the greater fracture prevalence.
- 1 June 2003
- Published by Springer Nature in Osteoporosis International
- Vol. 14 (5) , 396-403
Bone mineral density and fractures among alcohol-dependent women in treatment and in recovery
Women are at higher risk for osteoporosis, but most of the literature examining the effect of alcohol abuse on bone mineral density (BMD) has been in men. The aim of this study was to determine differences in BMD and fracture prevalence among women in treatment for alcohol abuse, in recovery and non-alcohol-dependent women. This cross-sectional study was completed at two residential substance abuse centers in Iowa (USA). The patients were Caucasian women, aged 18–70 years, in treatment for alcohol abuse and dependence (n=228); in recovery and abstaining from alcohol (n=156); and women with no history of alcohol abuse (n=447). The main outcome measures were femoral neck and lumbar spine BMD measured by dual-energy X-ray absorptiometry (DXA); self-reported lifetime fracture prevalence. After adjusting for age and menopausal status, women in treatment had BMDs that were 7.7% (ppppp<0.01). Women in recovery also reported significantly greater numbers of fractures following sobriety than their paired non-alcohol-dependent counterparts. Alcohol abuse and dependence was associated with lower femoral neck and lumbar spine BMD. Women with histories of alcohol dependence had a higher lifetime prevalence of fractures, including time periods before the onset of problem drinking and following abstinence, suggesting that factors other than acute intoxication contributed to the greater fracture prevalence.
- 1 May 2001
- Published by Elsevier in Fertility and Sterility
- Vol. 75 (5) , 871-877
Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception
- 1 May 2001
- Published by Elsevier in Fertility and Sterility
- Vol. 75 (5) , 871-877
Magnitude and variability of sequential estradiol and progesterone concentrations in women using depot medroxyprogesterone acetate for contraception